![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 23, 2010 3:00:24 PM
The device, dubbed Synergy, features a biodegradable coating and aims to address some concerns associated with earlier generations of drug-coated stents.
Stents are tiny mesh tubes used to prop open clogged arteries. Some versions of the devices are coated with drugs that help prevent the formation of scar tissue. However, there is some evidence that drug-coated stents increase the risk that a patient will develop dangerous clots.
Boston Scientific's Synergy stent differs from earlier technologies, as the coating degrades over time, leaving behind a bare-metal stent.
The clinical trial will test the product on 291 patents in Australia, Europe and New Zealand.
Boston Scientific (NYSE: BSX) is based in Natick, Mass., but has major operations in Arden Hills and Maple Grove. It develops and manufactures stents in Minnesota.
Read more: Boston Scientific to study new stent - Minneapolis / St. Paul Business Journal
Recent BSX News
- Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results • PR Newswire (US) • 07/01/2024 12:00:00 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc. • PR Newswire (US) • 06/18/2024 05:23:00 PM
- Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc. • PR Newswire (US) • 06/18/2024 11:00:00 AM
- Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific • GlobeNewswire Inc. • 06/18/2024 11:00:00 AM
- MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints • PR Newswire (US) • 05/18/2024 03:03:00 PM
- Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors • PR Newswire (US) • 05/08/2024 08:00:00 PM
- U.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures Trading • IH Market News • 04/24/2024 11:31:20 AM
- Boston Scientific Announces Results for First Quarter 2024 • PR Newswire (US) • 04/24/2024 10:30:00 AM
- Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module • PR Newswire (US) • 04/08/2024 04:00:00 AM
- Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results • PR Newswire (US) • 04/01/2024 12:00:00 PM
- Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon • PR Newswire (US) • 03/01/2024 11:55:00 AM
- Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes • PR Newswire (US) • 02/27/2024 09:15:00 PM
- Boston Scientific Announces Pricing of €2.0 Billion of Senior Notes • PR Newswire (US) • 02/23/2024 02:27:00 AM
- Boston Scientific to Participate in TD Cowen's 44th Annual Health Care Conference • PR Newswire (US) • 02/05/2024 01:00:00 PM
- Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 • PR Newswire (US) • 01/31/2024 11:30:00 AM
- U.S. Futures Waver Ahead of Fed Decision Amid Mixed Corporate Earnings; Oil Prices Slide • IH Market News • 01/31/2024 11:29:30 AM
- Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System • PR Newswire (US) • 01/31/2024 11:25:00 AM
- Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc. • PR Newswire (US) • 01/08/2024 09:55:00 PM
- Axonics Shares Climb 20% After Acquisition by Boston Scientific • Dow Jones News • 01/08/2024 04:36:00 PM
- Boston Scientific To Acquire Axonics For About $3.7 Billion • Dow Jones News • 01/08/2024 12:41:00 PM
- Axonics Announces Definitive Agreement to be Acquired by Boston Scientific • Business Wire • 01/08/2024 12:00:00 PM
- Boston Scientific Announces Agreement to Acquire Axonics, Inc. • PR Newswire (US) • 01/08/2024 12:00:00 PM
- Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results • PR Newswire (US) • 01/05/2024 01:00:00 PM
- Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation • PR Newswire (US) • 12/28/2023 09:00:00 PM
- Boston Scientific Closes Acquisition of Relievant Medsystems, Inc. • PR Newswire (US) • 11/17/2023 02:00:00 PM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM